{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:00:36Z","timestamp":1792602036854,"version":"4.5.0"},"reference-count":32,"publisher":"The Korean Society for Reproductive Medicine","issue":"3","license":[{"start":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T00:00:00Z","timestamp":1629936000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003052","name":"Ministry of Trade, Industry and Energy","doi-asserted-by":"publisher","award":["20003838"],"award-info":[{"award-number":["20003838"]}],"id":[{"id":"10.13039\/501100003052","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ecerm.org"],"crossmark-restriction":true},"short-container-title":["Clin Exp Reprod Med"],"published-print":{"date-parts":[[2021,9,1]]},"abstract":"<jats:p>We performed a systematic review and meta-analysis to evaluate whether intralipid administration improved the outcomes of in vitro fertilization. Online databases (PubMed, Cochrane Library, Medline, and Embase) were searched until March 2020. Only randomized controlled trials (RCTs) that assessed the role of intralipid administration during in vitro fertilization were considered. We analyzed the rates of clinical pregnancy and live birth as primary outcomes. Secondary outcomes included the rates of chemical pregnancy, ongoing pregnancy, and missed abortion. We reviewed and assessed the eligibility of 180 studies. Five RCTs including 840 patients (3 RCTs: women with repeated implantation failure, 1 RCT: women with recurrent spontaneous abortion, 1 RCT: women who had experienced implantation failure more than once) met the selection criteria. When compared with the control group, intralipid administration significantly improved the clinical pregnancy rate (risk ratio [RR], 1.48; 95% confidence interval [CI], 1.23\u20131.79), ongoing pregnancy rate (RR, 1.82; 95% CI, 1.31\u20132.53), and live birth rate (RR, 1.85; 95% CI, 1.44\u20132.38). However, intralipid administration had no beneficial effect on the miscarriage rate (RR, 0.75; 95% CI, 0.48\u20131.17). A funnel plot analysis revealed no publication bias. Our findings suggest that intralipid administration may benefit women undergoing in vitro fertilization, especially those who have experienced repeated implantation failure or recurrent spontaneous abortion. However, larger, well-designed studies are needed to confirm these findings.<\/jats:p>","DOI":"10.5653\/cerm.2020.04266","type":"journal-article","created":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T23:39:43Z","timestamp":1629934783000},"page":"203-210","update-policy":"https:\/\/doi.org\/10.5653\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Efficacy of intralipid administration to improve in vitro fertilization outcomes: A systematic review and meta-analysis"],"prefix":"10.5653","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1913-6528","authenticated-orcid":true,"given":"E Jung","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8427-4150","authenticated-orcid":true,"given":"Hye Nam","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1753-2674","authenticated-orcid":true,"given":"Min Kyoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5572-0898","authenticated-orcid":true,"given":"Sang Woo","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2329-1774","authenticated-orcid":true,"given":"Woo Sik","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3624","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0034-1375182"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4103\/0974-1208.117165"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2012.03.010"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2011.03.006"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.2012.01183.x"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2012.03.017"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1160\/th15-09-0739"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1177\/0148607100024002113"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.171.9.4837"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-015-3922-8"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/der164"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2019.1631280"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2016.06.026"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2019.06.007"},{"key":"ref15","first-page":"14","volume-title":"Intravenous intralipid therapy is not beneficial in having a live delivery in women aged 40-42 years with a previous history of miscarriage or failure to conceive despite embryo transfer undergoing in vitro fertilization-embryo transfer","author":"Check","year":"2016"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.4103\/jhrs.jhrs_28_18"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2015.07.080"},{"key":"ref18","first-page":"31","volume-title":"Intralipid infusion does not improve live birth rates in women with unexplained recurrent implantation failure and may increase the risk of congenital malformations, a double-blinded randomised controlled trial","author":"Gamaleldin","year":"2018"},{"key":"ref19","first-page":"85","volume-title":"Immune therapies for women with history of unsuccessful implantation undergoing IVF\/ICSI treatment: a Cochrane collaboration systematic review","author":"Asif","year":"2018"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/det117"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.2007.00473.x"},{"key":"ref22","first-page":"3011","volume-title":"PPARgamma and early human placental development","author":"Fournier","year":"2008"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2008.02842.x"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2004.04.005"},{"key":"ref25","first-page":"829","volume-title":"The peroxisome proliferator-activated receptor gamma regulates trophoblast cell differentiation in mink (Mustela vison)","author":"Desmarais","year":"2007"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.1994.tb01128.x"},{"key":"ref27","first-page":"3276","volume-title":"Peroxisome proliferator-activated receptor-gamma and its ligands attenuate biologic functions of human natural killer cells","author":"Zhang","year":"2004"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.1690453"},{"key":"ref29","first-page":"258","volume-title":"Duration of intralipid's suppressive effect on NK cell's functional activity","author":"Roussev","year":"2008"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.theriogenology.2010.10.030"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.1996.tb00495.x"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.2012.01111.x"}],"container-title":["Clinical and Experimental Reproductive Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ecerm.org\/upload\/pdf\/cerm-2020-04266.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/ecerm.org\/journal\/view.php?doi=10.5653\/cerm.2020.04266","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/ecerm.org\/upload\/pdf\/cerm-2020-04266.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:02:47Z","timestamp":1630454567000},"score":1,"resource":{"primary":{"URL":"http:\/\/ecerm.org\/journal\/view.php?doi=10.5653\/cerm.2020.04266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,1]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"URL":"https:\/\/doi.org\/10.5653\/cerm.2020.04266","relation":{},"ISSN":["2233-8233","2233-8241"],"issn-type":[{"value":"2233-8233","type":"print"},{"value":"2233-8241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,1]]},"assertion":[{"value":"2020-12-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-06","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-26","order":2,"name":"published","label":"Published online","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-01","order":3,"name":"published","label":"Print publication","group":{"name":"publication_history","label":"Publication History"}}]}}